在线国产一区二区_成人黄色片在线观看_国产成人免费_日韩精品免费在线视频_亚洲精品美女久久_欧美一级免费在线观看

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Americas

Hydroxychloroquine fails to prevent COVID-19: trial

Xinhua | Updated: 2020-06-04 14:06
Share
Share - WeChat
The drug hydroxychloroquine is displayed at the Rock Canyon Pharmacy in Provo, Utah, US, May 27, 2020. [Photo/Agencies]

CHICAGO - Hydroxychloroquine, an anti-malaria drug, was not statistically effective in preventing infection for people exposed to the novel coronavirus, a clinical trial showed on Wednesday.

The experiment, led by a team at the University of Minnesota, the United States, in March, was the first randomized clinical trial testing hydroxychloroquine for the post-exposure prevention of COVID-19, according to the university.

Researchers enrolled 821 adults from the United States and Canada, who had come into contact with someone confirmed with COVID-19 for more than 10 minutes at a distance of six feet (1.83 meters) or less.

All the participants were randomly assigned to receive either hydroxychloroquine, or a vitamin placebo, for five days.

Over the next two weeks, against laboratory test and from clinical signs, researchers found that 49 of the 414, or 11.83 percent, given the medicine got the COVID-19, compared to 58 of the 407, or 14.25 percent, on the placebo.

The scientists said the difference of about 2.4 percentage points in favor of the medicine was not considered statistically significant, which means hydroxychloroquine has no benefit over placebo in COVID-19 prevention.

Side effects, however, were more common with hydroxychloroquine group than those on the placebo -- 40.1 percent versus 16.8 percent -- no serious ones were reported though.

The trial results has been published in the New England Journal of Medicine.

US President Donald Trump has said he used it as a prophylaxis against COVID-19, but the Food and Drug Administration cautioned in late April against the use of it outside of the hospital setting due to the risk of cardiac rhythm problems.

As of 0100 GMT Thursday, confirmed COVID-19 cases have passed 6.3 million globally, with 383,318 deaths, showed the tally of Center for Systems Science and Engineering at Johns Hopkins University.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 日本少妇做爰全过程毛片 | 五月婷在线 | 成人羞羞国产免费 | 欧美成人精品一区二区三区在线看 | 日韩福利片 | 能看的毛片 | 黄色片免费网站 | 日韩理论片 | 亚洲福利一区 | 黄色三级在线 | 亚洲午夜视频在线观看 | 国产欧美综合一区二区三区 | 国产美女视频网站 | 国产欧美一区二区三区在线看蜜臀 | 国产原创精品 | 日韩视频在线免费观看 | 一级黄色小视频 | 久久都是精品 | 真实的国产乱xxxx在线 | 激情小说在线视频 | 在线国产小视频 | 国产一区二区三区久久 | 中文字幕在线观看网址 | 天天爽 | 欧美在线小视频 | www中文字幕 | 日本福利视频 | 天天爽天天爽 | 国产日韩精品一区二区 | av一区二区三区在线观看 | 日韩在线观看中文字幕 | 国产黄色精品 | 久久综合热 | 久热精品视频 | 99国产视频 | 亚洲一区久久 | 自拍视频一区 | 日本在线视频一区二区 | 在线看的av | a在线视频 | 操bbbbb|